These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1433 related items for PubMed ID: 18725838

  • 1. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
    Schneider EC, Rosenthal M, Gatsonis CG, Zheng J, Epstein AM.
    Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
    [Abstract] [Full Text] [Related]

  • 2. Market and beneficiary characteristics associated with enrollment in Medicare managed care plans and fee-for-service.
    Shimada SL, Zaslavsky AM, Zaborski LB, O'Malley AJ, Heller A, Cleary PD.
    Med Care; 2009 May; 47(5):517-23. PubMed ID: 19365291
    [Abstract] [Full Text] [Related]

  • 3. Trends in colorectal cancer testing among Medicare subpopulations.
    Fenton JJ, Cai Y, Green P, Beckett LA, Franks P, Baldwin LM.
    Am J Prev Med; 2008 Sep; 35(3):194-202. PubMed ID: 18619761
    [Abstract] [Full Text] [Related]

  • 4. Use of preventive services by Medicare fee-for-service beneficiaries: does spillover from managed care matter?
    Koroukian SM, Litaker D, Dor A, Cooper GS.
    Med Care; 2005 May; 43(5):445-52. PubMed ID: 15838408
    [Abstract] [Full Text] [Related]

  • 5. Colorectal cancer test use--Maryland, 2002-2006.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2007 Sep 14; 56(36):932-6. PubMed ID: 17851446
    [Abstract] [Full Text] [Related]

  • 6. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
    O'Malley AS, Forrest CB, Feng S, Mandelblatt J.
    Arch Intern Med; 2005 Oct 10; 165(18):2129-35. PubMed ID: 16217003
    [Abstract] [Full Text] [Related]

  • 7. Increase in screening for colorectal cancer in older Americans: results from a national survey.
    Chen X, White MC, Peipins LA, Seeff LC.
    J Am Geriatr Soc; 2008 Aug 10; 56(8):1511-6. PubMed ID: 18662217
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of claims, medical records, and self-report for measuring fecal occult blood testing among medicare enrollees in fee for service.
    Schenck AP, Klabunde CN, Warren JL, Peacock S, Davis WW, Hawley ST, Pignone M, Ransohoff DF.
    Cancer Epidemiol Biomarkers Prev; 2008 Apr 10; 17(4):799-804. PubMed ID: 18381471
    [Abstract] [Full Text] [Related]

  • 9. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC, Fendrick AM, Abrahamse PH, Dong Q, Patterson SK, Bernstein SJ.
    Womens Health Issues; 2005 Apr 10; 15(6):249-57. PubMed ID: 16325138
    [Abstract] [Full Text] [Related]

  • 10. Health plan policies and programs for colorectal cancer screening: a national profile.
    Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML.
    Am J Manag Care; 2004 Apr 10; 10(4):273-9. PubMed ID: 15124504
    [Abstract] [Full Text] [Related]

  • 11. Trends in colorectal cancer test use in the medicare population, 1998-2005.
    Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML.
    Am J Prev Med; 2009 Jul 10; 37(1):1-7. PubMed ID: 19423273
    [Abstract] [Full Text] [Related]

  • 12. The use of screening colonoscopy for patients cared for by the Department of Veterans Affairs.
    El-Serag HB, Petersen L, Hampel H, Richardson P, Cooper G.
    Arch Intern Med; 2006 Nov 13; 166(20):2202-8. PubMed ID: 17101937
    [Abstract] [Full Text] [Related]

  • 13. Barriers to colorectal cancer screening among Medicare consumers.
    Klabunde CN, Schenck AP, Davis WW.
    Am J Prev Med; 2006 Apr 13; 30(4):313-9. PubMed ID: 16530618
    [Abstract] [Full Text] [Related]

  • 14. Dually eligible and colorectal cancer screening: too little, too late?
    Carcaise-Edinboro P, Bradley CJ, Dahman B.
    J Health Care Poor Underserved; 2009 Aug 13; 20(3):854-65. PubMed ID: 19648712
    [Abstract] [Full Text] [Related]

  • 15. Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?
    Keating NL, Landrum MB, Meara E, Ganz PA, Guadagnoli E.
    J Natl Cancer Inst; 2005 Feb 16; 97(4):257-64. PubMed ID: 15713960
    [Abstract] [Full Text] [Related]

  • 16. Quality assessments by sick and healthy beneficiaries in traditional Medicare and Medicare managed care.
    Keenan PS, Elliott MN, Cleary PD, Zaslavsky AM, Landon BE.
    Med Care; 2009 Aug 16; 47(8):882-8. PubMed ID: 19543123
    [Abstract] [Full Text] [Related]

  • 17. Comparison of performance of traditional Medicare vs Medicare managed care.
    Landon BE, Zaslavsky AM, Bernard SL, Cioffi MJ, Cleary PD.
    JAMA; 2004 Apr 14; 291(14):1744-52. PubMed ID: 15082702
    [Abstract] [Full Text] [Related]

  • 18. Comparison of cancer diagnosis and treatment in Medicare fee-for-service and managed care plans.
    Riley GF, Warren JL, Potosky AL, Klabunde CN, Harlan LC, Osswald MB.
    Med Care; 2008 Oct 14; 46(10):1108-15. PubMed ID: 18815533
    [Abstract] [Full Text] [Related]

  • 19. Fecal occult blood test use by Kansas medicare beneficiaries.
    Engelman KK, Ellerbeck EF, Ahluwalia JS, Nazir N, Velasco A.
    Prev Med; 2001 Dec 14; 33(6):622-6. PubMed ID: 11716659
    [Abstract] [Full Text] [Related]

  • 20. Geographic area variations in the Medicare health plan era.
    Keenan PS, Cleary PD, O'Malley AJ, Landon BE, Zaborski L, Zaslavsky AM.
    Med Care; 2010 Mar 14; 48(3):260-6. PubMed ID: 20182269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.